09.06.2025
Schedule Test
te for the Wordfence Web Application Firewall was unsuccessful. The last successful update check was January 17, 2024 12:12 am,...
Acino
News
18.01.2024
Top Employer 2024: Acino South Africa receives certification for the third time running
For the third consecutive year, Acino South Africa has been awarded with the Top Employer certification. The Top Employer certification is one...
04.12.2023
Acino Completes Acquisition of M8 Pharmaceuticals Significantly Expanding Presence and Capabilities in Latin America
With nearly 300 new employees on board, Acino will enhance its presence in Latin America and strengthen its business through...
18.11.2023
Acino recognizes World Antimicrobial Resistance Awareness Week 2023
Antimicrobial resistance (AMR) is a global health concern that threatens the effectiveness of antibiotics and other antimicrobial medicines. It has the...
19.10.2023
Cardiovascular diseases get Acino employees to open their hearts
In line with Acino’s commitment to improving patients’ lives, we regularly organise health awareness initiatives with our employees, the ambassadors...
29.09.2023
Acino Recognizes World Heart Day 2023
Acino, recognizes the significance of cardiovascular health and is dedicated to advancing heart care through innovative solutions and patient education....
26.09.2023
Meet Eva Kopecna, Global Head Regulatory Affairs, Medical and Pharmacovigilance
Dedication and expertise are key qualities needed to deliver flexible solutions. We are fortunate to have a group of experts...
20.09.2023
Acino Significantly Expands Presence and Capabilities in Latin America Through Acquisition of M8 Pharmaceuticals
Over 300 M8 employees, product portfolio and pipeline to enhance Acino’s footprint and strategic position in key Latin American markets....
14.09.2023
Acino releases company’s first ever Sustainability Report
Report reflects Acino’s commitment to Environmental, Social, and Governance sustainability including goal of reaching carbon neutrality by 2050. ZURICH, Switzerland,...